392 related articles for article (PubMed ID: 9554704)
1. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
Petroff OA; Rothman DL
Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff O; Rothman D; Behar K
Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
[TBL] [Abstract][Full Text] [Related]
4. The new anti-epileptic drugs.
Murphy R
Ir Med J; 1995; 88(6):198-9. PubMed ID: 8575915
[No Abstract] [Full Text] [Related]
5. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
Petroff OA; Behar KL; Mattson RH; Rothman DL
J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
[TBL] [Abstract][Full Text] [Related]
6. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
Rothman DL; Petroff OA; Behar KL; Mattson RH
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5662-6. PubMed ID: 8516315
[TBL] [Abstract][Full Text] [Related]
7. [Current viewpoints in the treatment of epilepsies: role of new antiepileptics?].
Despland PA
Praxis (Bern 1994); 1995 Sep; 84(38):1036-41. PubMed ID: 7481302
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin increases human brain homocarnosine and improves seizure control.
Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
[TBL] [Abstract][Full Text] [Related]
9. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).
Manor D; Rothman DL; Mason GF; Hyder F; Petroff OA; Behar KL
Neurochem Res; 1996 Sep; 21(9):1031-41. PubMed ID: 8897466
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
[TBL] [Abstract][Full Text] [Related]
11. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
[TBL] [Abstract][Full Text] [Related]
12. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
Srinivasan J; Richens A
Drug Saf; 1994 May; 10(5):395-405. PubMed ID: 8037889
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
[TBL] [Abstract][Full Text] [Related]
14. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
Petroff OA; Rothman DL; Behar KL; Mattson RH
Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
[TBL] [Abstract][Full Text] [Related]
15. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
Petroff OA; Rothman DL; Behar KL; Mattson RH
Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
[TBL] [Abstract][Full Text] [Related]
16. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
[TBL] [Abstract][Full Text] [Related]
17. Status epilepticus during vigabatrin treatment: a report of three cases.
de Krom MC; Verduin N; Visser E; Kleijer M; Scholtes F; De Groen JH
Seizure; 1995 Jun; 4(2):159-62. PubMed ID: 7670770
[TBL] [Abstract][Full Text] [Related]
18. (4S)-4-amino-5,6-heptadienoic acid (MDL 72483): a potent anticonvulsant GABA-T inhibitor.
Sarhan S; Casara P; Knödgen B; Seiler N
Neurochem Res; 1991 Mar; 16(3):285-93. PubMed ID: 1780030
[TBL] [Abstract][Full Text] [Related]
19. Metabolic precursors and compartmentation of cerebral GABA in vigabatrin-treated rats.
Preece NE; Cerdán S
J Neurochem; 1996 Oct; 67(4):1718-25. PubMed ID: 8858958
[TBL] [Abstract][Full Text] [Related]
20. Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase.
Chen Z; Silva AC; Yang J; Shen J
J Neurosci Res; 2005 Feb; 79(3):383-91. PubMed ID: 15619231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
